Cargando…

Feasibility of 10-Day Use of a Continuous Glucose-Monitoring System in Adults With Type 1 Diabetes

OBJECTIVE—The purpose of this pilot study was to evaluate the feasibility of 10-day use of a transcutaneous, real-time, continuous glucose-monitoring (CGM) system. All previous reports using different CGM systems were for 3-, 5-, or 7-day use. RESEARCH DESIGN AND METHODS—On day 1, subjects received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, Satish K., Voelmle, Mary K., Gottlieb, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Emerging Treatments and Technologies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646024/ https://www.ncbi.nlm.nih.gov/pubmed/19033411 http://dx.doi.org/10.2337/dc08-1745

Ejemplares similares

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
por: Nauck, Michael, et al.
Publicado: (2009)

Novel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes
por: Dillon, E. Lichar, et al.
Publicado: (2009)

SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients : Effects of monotherapy with rimonabant, the first selective CB(1) receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008)

Racial/Ethnic Differences in Concerns About Current and Future Medications Among Patients With Type 2 Diabetes
por: Huang, Elbert S., et al.
Publicado: (2009)

Effect of Protein Kinase Cβ Inhibition on Renal Hemodynamic Function and Urinary Biomarkers in Humans With Type 1 Diabetes: A Pilot Study
por: Cherney, David Z.I., et al.
Publicado: (2009)

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
por: Rosenstock, Julio, et al.
Publicado: (2008)

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control: A randomized, double-blind, placebo-controlled study
por: DeFronzo, Ralph A., et al.
Publicado: (2008)

Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit
por: Kosiborod, Mikhail, et al.
Publicado: (2014)

Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity
por: Smith, Steve R., et al.
Publicado: (2008)

A New Luminescence Assay for Autoantibodies to Mammalian Cell–Prepared Insulinoma-Associated Protein 2
por: Burbelo, Peter D., et al.
Publicado: (2008)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
por: Aleppo, Grazia, et al.
Publicado: (2021)

Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: A prospective 6-month study
por: Garg, Satish K., et al.
Publicado: (2011)

Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
por: Tao, Rui, et al.
Publicado: (2021)

Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes
por: Davis, Georgia M., et al.
Publicado: (2021)

Impact of Ramadan fasting on glucose levels in women with gestational diabetes mellitus treated with diet alone or diet plus metformin: a continuous glucose monitoring study
por: Afandi, Bachar O, et al.
Publicado: (2017)

Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
por: Raj, Rishi, et al.
Publicado: (2022)

Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study
por: Valenzano, Marina, et al.
Publicado: (2021)

Search for Therapeutics Continues as SARS ‘Epidemic’ Abates
Publicado: (2012)

Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus
por: Fokkert, M J, et al.
Publicado: (2017)

Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring
por: Shen, Yun, et al.
Publicado: (2021)

Log-based software monitoring: a systematic mapping study
por: Cândido, Jeanderson, et al.
Publicado: (2021)

Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System
por: Calhoun, Peter, et al.
Publicado: (2018)

Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial
por: Singh, Lakshmi G., et al.
Publicado: (2020)

MeteoMex: open infrastructure for networked environmental monitoring and agriculture 4.0
por: Winkler, Robert
Publicado: (2021)

A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits
por: Dixon, Ronald F., et al.
Publicado: (2019)

Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes
por: Welsh, John B., et al.
Publicado: (2018)

Mobile phone enabled mental health monitoring to enhance diagnosis for severity assessment of behaviours: a review
por: Gopalakrishnan, Abinaya, et al.
Publicado: (2022)

Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial
por: Wada, Eri, et al.
Publicado: (2020)

Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases
por: Almurashi, Abdulhalim M., et al.
Publicado: (2023)

Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays
por: McClatchey, P. Mason, et al.
Publicado: (2019)

Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp
por: Ly, Trang T., et al.
Publicado: (2014)

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
por: Martin, Christopher T., et al.
Publicado: (2019)

Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
por: Smith, Ian P, et al.
Publicado: (2023)

Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen
por: Galindo, Rodolfo J., et al.
Publicado: (2020)

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
por: Castellana, Marco, et al.
Publicado: (2020)

FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis
por: Blissett, Robert, et al.
Publicado: (2022)

Commencement of flash glucose monitoring is associated with a decreased rate of depressive disorders among persons with diabetes (FLARE-NL7)
por: Bakker, Julia J, et al.
Publicado: (2022)

Insulin degludec overdose in an adolescent with type 1 diabetes: proactive management including monitoring using the Freestyle Libre flash glucose monitoring system
por: Thompson, Harmony, et al.
Publicado: (2018)

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
por: Ghazi, Tara, et al.
Publicado: (2014)

Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp
por: Nagl, Katrin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kchfg5q0svt125ibimj3660h0o